Keywords: vivus, stock, rising, impotence, challenge, markets, therapy

Vivus Stock Rising To Impotence Challenge

Article | 09 July 1998

Print This

Vivus, which markets the impotence therapy MUSE, an intra-urethralformulation of alprostadil, has seen a dramatic upturn in its share price ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in